Patient perspectives on treatment for mantle cell lymphoma and chronic lymphocytic leukemia in Japan-Reference-Cited by-同舟云学术

Patient perspectives on treatment for mantle cell lymphoma and chronic lymphocytic leukemia in Japan

Published:2024 Issue:2 Volume:64 Page:119-128
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:JCEH

Author:

Kiguchi Toru¹,Hiramatsu Yasushi²,Ota Shuichi³,Uchiyama Michihiro⁴,Matsuo Moe⁵,Okamura Miyu⁵,Morimoto Shimpei⁵,Tanizawa Yoshinori⁶,Tajimi Masaomi⁶,Payakachat Nalin⁷

Affiliation:

1. Division of Diabetes, Endocrinology and Hematology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan,

2. Department of Hematology and Oncology, Japanese Red Cross Society Himeji Hospital, Himeji, Japan,

3. Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan,

4. Department of Hematology, Japanese Red Cross Society Suwa Hospital, Suwa, Japan,

5. Syneos Health Clinical K.K., Tokyo, Japan,

6. Eli Lilly Japan K.K., Kobe, Japan,

7. Eli Lilly and Company, Indianapolis, IN, USA.

Publisher

Japanese Society for Lymphoreticular Tissue Research

Link

https://www.jstage.jst.go.jp/article/jslrt/64/2/64_24016/_pdf

Reference27 articles.

1. 1 Japanese Society of Hematology. Chapter II Lymphoma. 4 Mantle Cell Lymphoma. 2020 April [cited 2023 June 19]. In: Practical Guidelines for Hematological Malignancies, 2018, 2nd Supplementary version [Internet]. Japanese Society of Hematology, [cited 2023 June 19]. Available from: http://www.jshem.or.jp/gui-hemali/2_4.html.

2. 2 Izutsu K, Suzumiya J, Takizawa J et al. Real World Treatment Practices for Mantle Cell Lymphoma in Japan: An Observational Database Research Study (CLIMBER-DBR). J Clin Exp Hematop. 2021; 61: 135-144.

3. 3 . Patient Survey 2020: 2020. Available from: https://www.mhlw.go.jp/toukei/saikin/hw/kanja/20/index.html.

4. 4 Japanese Society of Hematology. Chapter I Leukemia. 5 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. 2020 April [cited 2023 June 19]. In: Practical Guidelines for Hematological Malignancies, 2018, 2nd Supplementary version [Internet]. Japanese Society of Hematology, [cited 2023 June 19]. Available from: http://www.jshem.or.jp/gui-hemali/1_5.html.

5. 5 Japanese Society of Hematology. Practical Guidelines for Hematological Malignancies, 2018, 2nd Supplementary version 2020. Available from: http://www.jshem.or.jp/gui-hemali/table.html.